Keith is a finance professional with over 20 years of public company experience across a wide range of industries, including pharmaceuticals and manufacturing. In his previous role as Corporate Controller of Cynapsus Therapeutics, he was responsible for building the finance function of a clinical-stage pharmaceutical development company. He was instrumental in completing an uplisting on the TSX, a private equity placement, an IPO on NASDAQ, as well as the ultimate successful sale of the company. Other management level roles included Controller of Sublimity Therapeutics, Assistant Corporate Controller of SMTC and Audit Manager with PwC. Keith has considerable knowledge of financial reporting, controls, and regulatory compliance in both the US and Canada. A designated Chartered Professional Accountant, Keith earned his MAcc degree from the University of Waterloo.